Why do we think CYDY will receive an EUA in Covid when you look at what just happened to HGEN after hitting their endpoint and having little to no SAEs (not to mention being on the NASDAQ, having high profile partners in multiple trials, and a much more experienced management and BOD)? This Brazil results will have to be a grand slam!